Lessons Learned from COVID-19 Clinical Trials
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
A recent survey by the Deloitte Center for Health Solutions of biopharma executives and other...
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
As we honor our military service members this Veterans Day, we take time to reflect on how we can...
In a recent report, the Centers for Disease Control and Prevention (CDC) found that four out of...
HealthVerity’s journey from an unknown startup to a major disrupter in the Healthcare industry ...
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Why government and public health agencies contract for the HealthVerity IPGE platform as a trusted...
In the first installment of our HealthVerity IPGE blog series covering the four foundational...
Traditional data aggregators are not enough The pharmaceutical industry is hitting a wall. Data aggregators, once considered reliable partners, are now liabilities facing significant challenges, including cyber threats, data restrictions, and opaque ...